Ribeiro, J. R., Schorl, C., Yano, N., Romano, N., Kim, K. K., Singh, R. K., & Moore, R. G. (2016). HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells. BioMed Central.
Chicago Style CitationRibeiro, J. R., C. Schorl, N. Yano, N. Romano, K. K. Kim, R. K. Singh, and R. G. Moore. HE4 Promotes Collateral Resistance to Cisplatin and Paclitaxel in Ovarian Cancer Cells. BioMed Central, 2016.
MLA CitationRibeiro, J. R., et al. HE4 Promotes Collateral Resistance to Cisplatin and Paclitaxel in Ovarian Cancer Cells. BioMed Central, 2016.
Warning: These citations may not always be 100% accurate.